Quantum Biopharma Ltd.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Quantum Biopharma Ltd. now
Current reporting with the operating signal separated from the noise.
Quantum Biopharma Ltd expected to post a loss of 42 cents a share - Earnings Preview
Investors are testing whether Quantum Biopharma Ltd.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Quantum BioPharma Ltd. Closes CAD$123,487.43 Debt Settlement Through Share Issuance
Investors are testing whether Quantum Biopharma Ltd.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Quantum BioPharma Ltd (QNTM) Earnings Forecast: Future EPS & Revenue Growth Estimates
Investors are testing whether Quantum Biopharma Ltd.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Missionirnewsbreaks Quantum Biopharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Expands Clinical Development Of Neuroprotective Therapy
The story matters when it changes Quantum Biopharma Ltd.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Quantum BioPharma Ltd. - Ordinary Shares
Investors are testing whether Quantum Biopharma Ltd.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend
The story matters when it changes Quantum Biopharma Ltd.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Quantum BioPharma Ltd. Announces Positive Results from Clinical Trial of unbuzzd™ Dietary Supplement for Alcohol Intoxication Relief
The story matters when it changes Quantum Biopharma Ltd.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM
The story matters when it changes Quantum Biopharma Ltd.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest QNTM filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Quantum Biopharma Ltd., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →